Issue of Equity

RNS Number : 3817H
Marlowe PLC
24 March 2020
 

24 March 2020

Marlowe plc

("Marlowe" or the "Company")

 

Issue of Equity

 

The Company announces that, following an exercise under a long-term incentive scheme, application has been made for 14,754 ordinary shares of 50 pence each in the Company ("New Ordinary Shares") to be admitted to trading on AIM. The New Ordinary Shares will rank pari-passu with existing ordinary shares, and it is expected that admission will occur at 8.00 a.m. on 30 March 2020.

 

Following admission of the New Ordinary Shares, the Company's issued ordinary share capital will comprise 45,883,835 ordinary shares, none of which are held in treasury. Therefore, the total number of ordinary shares with voting rights in Marlowe following admission will be 45,883,835.

 

The above figure of 45,883,835 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 



For further information:

www.marloweplc.com



Marlowe plc

0203 813 8498

Alex Dacre, Chief Executive

IR@marloweplc.com

Mark Adams, Group Finance Director




Cenkos Securities (Nominated Adviser & Joint Broker)

0207 397 8900

Nicholas Wells

Ben Jeynes

Harry Hargreaves




Joh. Berenberg, Gossler & Co. KG, London Branch (Joint Broker)

Ben Wright

Mark Whitmore

 

FTI Consulting

0203 207 7800

 

 

 

0203 727 1340

Nick Hasell


Alex Le May


 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEBBGDXCDDDGGS

Companies

Marlowe (MRL)
UK 100